Pergolide

Known as: Pergolide [Chemical/Ingredient], Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-, Pergolidum 
A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
BACKGROUND Case reports and echocardiographic studies suggest that the ergot-derived dopamine agonists pergolide and cabergoline… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Dopamine agonists are used as initial treatment in patients with Parkinson's disease (PD) to reduce incidence and severity of… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Restrictive valvular heart disease has been reported in patients with Parkinson's disease treated with pergolide… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole (PPX… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Although dopamine has been closely associated with prefrontal function, and with working memory in monkeys, the effects of… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To determine whether an association exists between pergolide and valvular heart disease. PATIENTS AND METHODS Three… (More)
Is this relevant?
2000
2000
Increased sedation, somnolence, and sleep episodes seem to occur with several, if not all, dopamine agonists and dopaminergic… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The effects of pergolide, a mixed D1/D2 receptor agonist, and bromocriptine, a selective D2 receptor agonist, were assessed in a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1984
1984
Pergolide, a long-acting central dopamine agonist, was used as monotherapy in 16 parkinsonian patients. A mean daily dose of 6.3… (More)
Is this relevant?
1980
1980
The activity of pergolide, an N-propylergoline derivative, has been tested for stimulation of central dopaminergic receptors… (More)
  • table 3
  • table 1
  • table 4
  • table 2
  • table 5
Is this relevant?